| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACER3
|
alkaline ceramidase 3
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3
|
|
ACYP1
|
acylphosphatase 1, erythrocyte (common) type
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADGRG6
|
adhesion G protein-coupled receptor G6
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AFAP1
|
actin filament associated protein 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH16A1
|
aldehyde dehydrogenase 16 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANK2
|
ankyrin 2, neuronal
|
|
ANO2
|
anoctamin 2, calcium activated chloride channel
|
|
APC
|
adenomatous polyposis coli
|
|
APITD1
|
apoptosis-inducing, TAF9-like domain 1
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
AUH
|
AU RNA binding protein/enoyl-CoA hydratase
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AZF1
|
azoospermia factor 1
|
|
B3GALT5
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BPIFB2
|
BPI fold containing family B, member 2
|
|
BPIFB6
|
BPI fold containing family B, member 6
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA2
|
carbonic anhydrase II
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV3
|
caveolin 3
|
|
CBX2
|
chromobox homolog 2
|
|
CCAT1
|
colon cancer associated transcript 1 (non-protein coding)
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCNT1
|
cyclin T1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD247
|
CD247 molecule
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CENPJ
|
centromere protein J
|
|
CERS2
|
ceramide synthase 2
|
|
CERS3
|
ceramide synthase 3
|
|
CERS4
|
ceramide synthase 4
|
|
CERS6
|
ceramide synthase 6
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFDP1
|
craniofacial development protein 1
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1
|
|
CLASP1
|
cytoplasmic linker associated protein 1
|
|
CLU
|
clusterin
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa
|
|
CRACR2A
|
calcium release activated channel regulator 2A
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3L4
|
cAMP responsive element binding protein 3-like 4
|
|
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEK
|
DEK proto-oncogene
|
|
DFNA53
|
deafness, autosomal dominant 53
|
|
DHRS4
|
dehydrogenase/reductase (SDR family) member 4
|
|
DIAPH2
|
diaphanous-related formin 2
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLEU1
|
deleted in lymphocytic leukemia 1 (non-protein coding)
|
|
DLEU2
|
deleted in lymphocytic leukemia 2 (non-protein coding)
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNA2
|
DNA replication helicase/nuclease 2
|
|
DNTT
|
DNA nucleotidylexotransferase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSG2
|
desmoglein 2
|
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EEA1
|
early endosome antigen 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELOVL1
|
ELOVL fatty acid elongase 1
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
EP300
|
E1A binding protein p300
|
|
EPO
|
erythropoietin
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FAIM
|
Fas apoptotic inhibitory molecule
|
|
FAM20C
|
family with sequence similarity 20, member C
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCRLA
|
Fc receptor-like A
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FFAR4
|
free fatty acid receptor 4
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FHL3
|
four and a half LIM domains 3
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXP3
|
forkhead box P3
|
|
FSHMD1A
|
facioscapulohumeral muscular dystrophy 1A
|
|
FUS
|
FUS RNA binding protein
|
|
FXN
|
frataxin
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GACAT2
|
gastric cancer associated transcript 2 (non-protein coding)
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRIN3B
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTT2B
|
glutathione S-transferase theta 2B (gene/pseudogene)
|
|
GTF2I
|
general transcription factor IIi
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HACL1
|
2-hydroxyacyl-CoA lyase 1
|
|
HBB
|
hemoglobin, beta
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC5
|
histone deacetylase 5
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
HTT
|
huntingtin
|
|
HULC
|
hepatocellular carcinoma up-regulated long non-coding RNA
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNG
|
interferon, gamma
|
|
IFNG-AS1
|
IFNG antisense RNA 1
|
|
IFT80
|
intraflagellar transport 80
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IL11
|
interleukin 11
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL18
|
interleukin 18
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
|
JUND
|
jun D proto-oncogene
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
LAMA5
|
laminin, alpha 5
|
|
LARP7
|
La ribonucleoprotein domain family, member 7
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LINC-PINT
|
long intergenic non-protein coding RNA, p53 induced transcript
|
|
LIPC
|
lipase, hepatic
|
|
LPL
|
lipoprotein lipase
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LTA
|
lymphotoxin alpha
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MAOA
|
monoamine oxidase A
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCM10
|
minichromosome maintenance complex component 10
|
|
MCOLN2
|
mucolipin 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR34A
|
microRNA 34a
|
|
MIR483
|
microRNA 483
|
|
MIR675
|
microRNA 675
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLANA
|
melan-A
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOV10
|
Mov10 RISC complex RNA helicase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYLK
|
myosin light chain kinase
|
|
MYO10
|
myosin X
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NANOG
|
Nanog homeobox
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NDNF
|
neuron-derived neurotrophic factor
|
|
NEAT1
|
nuclear paraspeckle assembly transcript 1 (non-protein coding)
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NEU4
|
sialidase 4
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NKRF
|
NFKB repressing factor
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPPB
|
natriuretic peptide B
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPTX1
|
neuronal pentraxin I
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRG1
|
neuregulin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUB1
|
negative regulator of ubiquitin-like proteins 1
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin
|
|
OTOF
|
otoferlin
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PANX1
|
pannexin 1
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PAPSS1
|
3'-phosphoadenosine 5'-phosphosulfate synthase 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARL
|
presenilin associated, rhomboid-like
|
|
PARN
|
poly(A)-specific ribonuclease
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
|
PHKG2
|
phosphorylase kinase, gamma 2 (testis)
|
|
PITX1
|
paired-like homeodomain 1
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PML
|
promyelocytic leukemia
|
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PON1
|
paraoxonase 1
|
|
POU3F3
|
POU class 3 homeobox 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PSEN1
|
presenilin 1
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTCSC3
|
papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGES2
|
prostaglandin E synthase 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPRS
|
protein tyrosine phosphatase, receptor type, S
|
|
PTX3
|
pentraxin 3, long
|
|
PTX4
|
pentraxin 4, long
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RBM38
|
RNA binding motif protein 38
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGN
|
regucalcin
|
|
RHBDF1
|
rhomboid 5 homolog 1 (Drosophila)
|
|
RHOF
|
ras homolog family member F (in filopodia)
|
|
RNR2
|
RNA, ribosomal cluster 2
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SAA1
|
serum amyloid A1
|
|
SAA2
|
serum amyloid A2
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCP2
|
sterol carrier protein 2
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC25A20
|
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20
|
|
SLC27A4
|
solute carrier family 27 (fatty acid transporter), member 4
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC47A1
|
solute carrier family 47 (multidrug and toxin extrusion), member 1
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SORBS1
|
sorbin and SH3 domain containing 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPAST
|
spastin
|
|
SPG19
|
spastic paraplegia 19 (autosomal dominant)
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRY
|
sex determining region Y
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
STRA13
|
stimulated by retinoic acid 13
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
SUPV3L1
|
suppressor of var1, 3-like 1 (S. cerevisiae)
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
TACR1
|
tachykinin receptor 1
|
|
TARBP1
|
TAR (HIV-1) RNA binding protein 1
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM3
|
transglutaminase 3
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPCN1
|
two pore segment channel 1
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRB
|
T cell receptor beta locus
|
|
TSC22D1
|
TSC22 domain family, member 1
|
|
TSC22D2
|
TSC22 domain family, member 2
|
|
TSC22D4
|
TSC22 domain family, member 4
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBE2G2
|
ubiquitin-conjugating enzyme E2G 2
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
USF1
|
upstream transcription factor 1
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCL
|
vinculin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VWF
|
von Willebrand factor
|
|
WASF2
|
WAS protein family, member 2
|
|
WFDC21P
|
WAP four-disulfide core domain 21, pseudogene
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
ZAK
|
sterile alpha motif and leucine zipper containing kinase AZK
|
